Newsfeeds - Spark Newswire

3 minute read

The Week Ahead In Biotech (May 30-June 4): FDA Decision For Eton’s Partnered Epilepsy Drug, ASCO Conference Gets Underway And More

Today, 9:57 PM

Biotech stocks advanced in the week ended May 27, tracking the overall positive sentiment of the broader market. Notwithstanding the week's strength, the sector has been one of the worst performers for the year-to-date period.

ABBV

6 minute read

88 Biggest Movers From Yesterday

By Lisa Levin

Today, 9:57 PM

Gainers Creatd, Inc. (NASDAQ: CRTD) shares jumped 58.5% to close at $1.28 on Thursday. Creatd’s board approved a rights offering of up to $40 million for 20 million shares at $2 per unit.

AFRM

2 minute read

Short Volatility Alert: Catalyst Biosciences

By Christopher Sappo

Today, 9:57 PM

On Modnay, shares of Catalyst Biosciences, Inc. (NASDAQ: CBIO) experienced volatile short activity. After the activity, the stock price went up +234.21% to $1.27. The overall sentiment for CBIO has been Bearish.

CBIO

2 minute read

25 Stocks Moving in Tuesday’s Pre-Market Session

By Lisa Levin

Today, 9:57 PM

Gainers BIMI International Medical Inc. (NASDAQ: BIMI) shares rose 136.4% to $1.43 in pre-market trading. BOQI International recently posted a Q1 loss of $0.27 per share.

ACRX

4 minute read

58 Biggest Movers From Yesterday

By Lisa Levin

Today, 9:57 PM

Gainers Catalyst Biosciences, Inc. (NASDAQ: CBIO) gained 234.2% to close at $1.27 after the company announced it sold its complement portfolio for $60 million.

ADGI

1 minute read

Catalyst Biosciences Stock More Than Doubles After Assets Sale To Vertex

By Vandana Singh

Today, 9:57 PM

Catalyst Biosciences Inc (NASDAQ:CBIO) has agreed to sell its portfolio of protease medicines that regulate complement to Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) for $60…

BIIB

1 minute read

Pre-Market Outlook

Benzinga Pro’s Top 5 Stocks To Watch For Monday, May 23, 2022: NVDA, RDBX, CBIO, VRCA, CWH

By Benzinga Newsdesk

Today, 9:57 PM

Today's 5 Stock Ideas: NVIDIA (NVDA) - Will report quarterly results Wednesday after market close. Redbox (RDBX) - One of the most popular stocks among the retail trader group over the last couple weeks.

CBIO

1 minute read

Legal
News

Julian Singer Says On April 20, JDS1 Filed Complaint Against Catalyst Biosciences In The Delaware Court Of Chancery

By Benzinga Newsdesk

Today, 9:57 PM

-SEC Filing

CBIO

2 minute read

Earnings

Looking Into Catalyst Biosciences’s Return On Capital Employed

By Benzinga Insights

Today, 9:57 PM

According to data from Benzinga Pro, during Q4, Catalyst Biosciences's (NASDAQ:CBIO) reported sales totaled $2.44 million. Despite a 19.45% increase in earnings, the company posted a loss of $20.33 million.

CBIO

2 minute read

Movers

12 Health Care Stocks Moving In Tuesday’s After-Market Session

By Benzinga Insights

Today, 9:57 PM

Gainers

ARDS